Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

367
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
367
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

355
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
355
Group Design02:01

Group Design

11.0K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
11.0K
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of pneumatic tube systems on next-generation viscoelastic coagulation test devices in septic patients and healthy individuals: Results of the randomized controlled VETaPT trial.

Scientific reports·2026
Same author

Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysis.

Journal of neurology·2026
Same author

Etiology- and age-specific timing of death by neurologic criteria evaluation and declaration in clinical practice.

Critical care (London, England)·2026
Same author

Myelodysplastic syndrome with concomitant <i>SF3B1</i> mutation and deletion of chromosome 5 long arm: outcomes and response to treatment.

Haematologica·2026
Same author

Cardiovascular Health Among Employees of a Brazilian Tertiary Hospital Assessed by the Life's Essential 8 Score: A Cross-Sectional Pilot Study.

Journal of clinical medicine·2026
Same author

Teleneurology vs On-Site Neurology Consultation for Postadmission Hospital Care of Stroke.

JAMA neurology·2026

Related Experiment Video

Updated: Mar 18, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

Randomized controlled trials - a matter of design.

Peter Markus Spieth1, Anne Sophie Kubasch2, Ana Isabel Penzlin3

  • 1Department of Anesthesiology and Critical Care Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Saxony, Germany; Center for Clinical Research and Management Education, Division of Health Care Sciences, Dresden International University, Dresden, Saxony, Germany.

Neuropsychiatric Disease and Treatment
|June 30, 2016
PubMed
Summary

This review provides guidance on designing, conducting, and reporting high-quality randomized controlled trials (RCTs). It emphasizes objective reporting of all results and maintaining clinical equipoise through interim analyses for better evidence-based medicine.

Keywords:
CONSORTRCTrandomized clinical trialsstudy designvalidity

More Related Videos

A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.3K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 18, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
A Within-Subject Experimental Design using an Object Location Task in Rats
09:28

A Within-Subject Experimental Design using an Object Location Task in Rats

Published on: May 6, 2021

5.3K
Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.8K

Area of Science:

  • Clinical Research Methodology
  • Evidence-Based Medicine

Background:

  • Randomized controlled trials (RCTs) are fundamental to evidence-based medicine.
  • Translating research findings into clinical practice relies heavily on RCTs.

Purpose of the Study:

  • To review common RCT designs and quality indicators.
  • To offer guidance on critically evaluating clinical research.
  • To discuss the principle of equipoise in clinical science, particularly in critical care and neurology.

Main Methods:

  • Literature review of educational materials, review articles, methodological studies, and published clinical trials.
  • Searches conducted on MEDLINE, PubMed, and ClinicalTrials.gov.

Main Results:

  • Key recommendations for RCTs include a priori definition of clinically relevant endpoints.
  • Objective reporting and publication of both significant and nonsignificant results are crucial.
  • Adherence to Consolidated Standards of Reporting Trials (CONSORT) guidelines and public trial registration are recommended.
  • Disclosure of conflicts of interest and funding sources is essential.
  • Preplanned interim analyses can help maintain clinical equipoise by assessing trial progress and guiding continuation or termination decisions.

Conclusions:

  • Implementing these recommendations enhances the quality and interpretability of RCTs.
  • Adherence to methodological standards and ethical principles like equipoise improves the reliability of clinical research.
  • Effective RCT design and reporting are vital for advancing evidence-based medical practice.